Are increased endocannabinoid plasma levels associated with coronary circulatory dysfunction in obese individuals?
Elevated endocannabinoid plasma levels may serve as a novel endogenous cardiovascular risk factor for coronary circulatory dysfunction in obesity.
Increased EC plasma levels of AEA and 2-AG are associated with coronary circulatory dysfunction in obese individuals. This observation might suggest increases in EC plasma levels as a novel endogenous cardiovascular risk factor in obesity, but needing further investigations.
Quercioli et al. (Tue,) studied this question.